Regardless, it has become increasingly clear that the γc cytokine family represents a group of cytokines that support the fundamental attributes T cells and understanding how to exploit these cytokines for therapeutic use is critical for next generation cancer clinical trials involving vaccines, checkpoint inhibitors and ACT therapy. The gene discussed is GC; the disease is cancer.